Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Innovotech Inc. (V:IOT)

Business Focus: Biotechnology & Medical Research

Sector:  Healthcare Industry:  Biotechnology & Medical Research
 
See Regulatory Filings on SEDAR
Company Contact
Address: 2011 94 St NW Suite 101
EDMONTON AB T6N 1H1
Tel: N/A
Website: www.innovotech.ca
IR: See website
Key People
N/A    
Business Overview
Innovotech Inc is a Canada-based company, which operates in the field of biofilm product development, practical services and solutions for dealing with medical, agricultural and industrial problems caused by microbial biofilms. The Company's current products include human and veterinary biofilm susceptibility tests, a seed treatment designed to combat both bacterial and fungal diseases, and an assay used in growing microbal biofilms for research purposes. The Company's products are effective against such diseases as Powdery Mildew on lettuce, White Mould on beans, Bacterial Spot on tomatoes and Fire Blight on apples. The Company's products include InnovoSIL, MBEC Assay Agress and AgreGuard.
Financial Overview
For the three months ended 31 March 2020, Innovotech Inc revenues decreased 43% to C$126K. Net loss increased from C$15K to C$115K. Revenues reflect Contract research fees decrease of 54% to C$69K, Product sales decrease of 21% to C$57K. Higher net loss reflects General and Administrative increase of 10% to C$177K (expense), Research and development increase of 94% to C$9K (expense).
Employees: 16 as of Mar 13, 2012
Reporting Currency: Canadian Dollars
Enterprise value: $5.80M as of Mar 31, 2020
Annual revenue (TTM): $0.89M as of Mar 31, 2020
EBITDA (TTM): -$0.13M as of Mar 31, 2020
Net annual income (TTM): -$0.15M as of Mar 31, 2020
Free cash flow (TTM): $0.07M as of Mar 31, 2020
Net Debt Last Fiscal Year: $0.02M as of Mar 31, 2020
Shares outstanding: 36,239,612 as of Mar 31, 2020
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization